Market research
FMS Fresenius Medical Care Corporation
NYSE USD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 12B
- P/E ratio
- 11.92
- Analyst target
- 23.8388
- Dividend yield
- 3.8%
- Beta
- 0.81
Profile
Instrument facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- Not available
- Market cap
- 12B
- P/E ratio
- 11.92
- Analyst target
- 23.8388
- Dividend yield
- 3.8%
- Beta
- 0.81
About
About Fresenius Medical Care Corporation
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Research context
Fresenius Medical Care Corporation appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the FMS discussion.
5 years, 7 months ago
Fresenius Medical Care AG & Co. KGaA is currently in a long term uptrend where the price is trading 1.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.
Fresenius Medical Care AG & Co. KGaA's total revenue sank by 3.9% to $4B since the same quarter in the previous year.
Its net income has dropped by 48.3% to $177M since the same quarter in the previous year.
Finally, its free cash flow grew by 178.5% to $278M since the same quarter in the previous year.
Based on the above factors, Fresenius Medical Care AG & Co. KGaA gets an overall score of 3/5.